VIEMED HLTHCARE (Germany) Performance
| VIJ Stock | EUR 7.70 0.05 0.65% |
The entity has a beta of -0.051, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning VIEMED HLTHCARE are expected to decrease at a much lower rate. During the bear market, VIEMED HLTHCARE is likely to outperform the market. At this point, VIEMED HLTHCARE INC has a negative expected return of -0.13%. Please make sure to validate VIEMED HLTHCARE's information ratio, potential upside, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if VIEMED HLTHCARE INC performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VIEMED HLTHCARE INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
VIEMED |
VIEMED HLTHCARE Relative Risk vs. Return Landscape
If you would invest 845.00 in VIEMED HLTHCARE INC on November 6, 2024 and sell it today you would lose (75.00) from holding VIEMED HLTHCARE INC or give up 8.88% of portfolio value over 90 days. VIEMED HLTHCARE INC is currently producing negative expected returns and takes up 2.4331% volatility of returns over 90 trading days. Put another way, 21% of traded stocks are less volatile than VIEMED, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
VIEMED HLTHCARE Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VIEMED HLTHCARE's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VIEMED HLTHCARE INC, and traders can use it to determine the average amount a VIEMED HLTHCARE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0528
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VIJ |
Estimated Market Risk
| 2.43 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VIEMED HLTHCARE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VIEMED HLTHCARE by adding VIEMED HLTHCARE to a well-diversified portfolio.
VIEMED HLTHCARE Fundamentals Growth
VIEMED Stock prices reflect investors' perceptions of the future prospects and financial health of VIEMED HLTHCARE, and VIEMED HLTHCARE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VIEMED Stock performance.
| Return On Equity | 0.0859 | |||
| Return On Asset | 0.0436 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.06 % | |||
| Shares Outstanding | 38.02 M | |||
| Price To Earning | 7.98 X | |||
| Revenue | 133.29 M | |||
| EBITDA | 22.57 M | |||
| Cash And Equivalents | 31.1 M | |||
| Cash Per Share | 0.79 X | |||
| Total Debt | 9.92 M | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 2.46 X | |||
| Cash Flow From Operations | 39.13 M | |||
| Earnings Per Share | 0.18 X | |||
About VIEMED HLTHCARE Performance
By analyzing VIEMED HLTHCARE's fundamental ratios, stakeholders can gain valuable insights into VIEMED HLTHCARE's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if VIEMED HLTHCARE has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if VIEMED HLTHCARE has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company was founded in 2006 and is headquartered in Lafayette, Louisiana. VIEMED HLTHCARE operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 528 people.Things to note about VIEMED HLTHCARE INC performance evaluation
Checking the ongoing alerts about VIEMED HLTHCARE for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VIEMED HLTHCARE INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VIEMED HLTHCARE INC generated a negative expected return over the last 90 days |
- Analyzing VIEMED HLTHCARE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VIEMED HLTHCARE's stock is overvalued or undervalued compared to its peers.
- Examining VIEMED HLTHCARE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VIEMED HLTHCARE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of VIEMED HLTHCARE's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VIEMED HLTHCARE's stock. These opinions can provide insight into VIEMED HLTHCARE's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for VIEMED Stock analysis
When running VIEMED HLTHCARE's price analysis, check to measure VIEMED HLTHCARE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIEMED HLTHCARE is operating at the current time. Most of VIEMED HLTHCARE's value examination focuses on studying past and present price action to predict the probability of VIEMED HLTHCARE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIEMED HLTHCARE's price. Additionally, you may evaluate how the addition of VIEMED HLTHCARE to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |